A Revisited Strategy for Antiepileptic Drug Development in Children-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Revisited Strategy for Antiepileptic Drug Development in Children

Published:2013-01-24 Issue:3 Volume:27 Page:185-195
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Chiron Catherine,Kassai Behrouz,Dulac Olivier,Pons Gerard,Nabbout Rima

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

http://link.springer.com/content/pdf/10.1007/s40263-012-0035-9.pdf

Reference44 articles.

1. Rheims S, Cucherat M, Arzimanoglou A, et al. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008;5(8):e166.

2. Bosch X. Pediatric medicine: Europe follows U.S. in testing drugs for children [letter]. Science. 2005;309(5742):1799.

3. Chiron C, Dulac O, Pons G. Antiepileptic drug development in children: considerations for a revisited strategy. Drugs. 2008;68(1):17–25.

4. Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997;26(2):389–95.

5. Appleton RE, Peters AC, Mumford JP, et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40(11):1627–33.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment in infants and young children with epilepsy: Off‐label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children;Epilepsia Open;2022-11-16

2. The role of cannabinoids in epilepsy treatment: a critical review of efficacy results from clinical trials;Epileptic Disorders;2020-01

3. Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions;Drugs;2019-11-16

4. Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy;Expert Opinion on Drug Safety;2018-09-17

5. Off-label use and manipulations of antiepileptic drugs in children: Analysis of the outpatient prescriptions in a tertiary center;Epilepsy & Behavior;2018-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3